CD8A and autoimmune disease: In autoimmune diseases, autoreactive T cells must be continually kept in check through inhibitory receptor engagement, but in SjS, strong CD8(+) activation is observed, which supports an ineffective PD-L1 pathway in such cases (55, 56).